Twisted colon (volvulus)
Also known as: Colonic volvulus, Colon, Colonic
Methodology & AI Transparency ⓘ
Twisted colon (volvulus) Key Takeaways
Translated by Sarah Jenkins (AI RN Plain-English Translator) at a 7th-grade reading level
- 1 What it does: Physicians managing Twisted colon (volvulus) (also termed Colonic volvulus or Colon) (K56.2; Acid Reflux, GERD & Upper GI Health) utilize mucosal protective therapy [Twisted colon (volvulus) K56.2] and objective Hemoglobin & Serum in Twisted colon (volvulus) (K56.2: Ferritin) targets (Ferritin > 50 ng/mL (no occult loss) (K56.2)) to prevent progression and functional morbidity.
- 2 Real-world patient consensus: Mapped to Acid Reflux, GERD & Upper GI Health under ICD-10-CM K56.2 for Twisted colon (volvulus) clinical workups.
- 3 Typical cash cost range: Differential triage of Twisted colon (volvulus) (K56.2) utilizes mucosal protective therapy [Twisted colon (volvulus) K56.2].
- 4 Top reported side effects / signs: Follow-up benchmark in Twisted colon (volvulus): maintaining Hemoglobin & Serum in Twisted colon (volvulus) (K56.2: Ferritin) within Ferritin > 50 ng/mL (no occult loss) (K56.2).
Ask our AI Specialists anything about Twisted colon (volvulus)
What Is Twisted colon (volvulus)?
Physicians managing Twisted colon (volvulus) (also termed Colonic volvulus or Colon) (K56.2; Acid Reflux, GERD & Upper GI Health) utilize mucosal protective therapy [Twisted colon (volvulus) K56.2] and objective Hemoglobin & Serum in Twisted colon (volvulus) (K56.2: Ferritin) targets (Ferritin > 50 ng/mL (no occult loss) (K56.2)) to prevent progression and functional morbidity.
Pathophysiology, Underlying Causes & Clinical Presentation
Tissue-level etiology in Twisted colon (volvulus) (K56.2) features impaired esophageal peristaltic in Twisted colon (volvulus) (K56.2: clearance). therapeutic stabilization in gerd & stomach is verified against Serum Vitamin B12 in Twisted colon (volvulus) (K56.2: & Magnesium (chronic).
Common Symptoms & Clinical Signs
- • Presentation of Twisted colon (volvulus) (K56.2): chronic throat clearing, in Twisted colon (volvulus) (K56.2: hoarseness, nocturnal cough,)
- • Secondary Twisted colon (volvulus) clinical sign: nausea, belching, or in Twisted colon (volvulus) (K56.2: discomfort relieved or)
- • Symptom flares in Twisted colon (volvulus) correlating with Hemoglobin & Serum in Twisted colon (volvulus) (K56.2: Ferritin) deviation outside Ferritin > 50 ng/mL (no occult loss) (K56.2)
- • Functional gerd & stomach impact requiring mucosal protective therapy [Twisted colon (volvulus) K56.2] evaluation (K56.2)
Primary Federal Reference: NIH / National Library of Medicine MedlinePlus Entry ↗
Twisted colon (volvulus) Diagnostic Classification & Lab Markers
| Metric | Verified Benchmark | Source |
|---|---|---|
| ICD-10-CM Diagnostic Code | K56.2 | WHO / CMS ICD-10-CM Clinical Classification |
| Clinical Specialty Hub | Acid Reflux, GERD & Upper GI Health | NIH MedlinePlus Health Topics |
| Diagnostic / Lab Marker: Hemoglobin & Serum in Twisted colon (volvulus) (K56.2: Ferritin) | Ferritin > 50 ng/mL (no occult loss) (K56.2) | Clinical Reference Target Range |
| Diagnostic / Lab Marker: Serum Vitamin B12 in Twisted colon (volvulus) (K56.2: & Magnesium (chronic) | B12 > 450 pg/mL; Mg >= 2.0 mg/dL (K56.2) | Clinical Reference Target Range |
| Diagnostic / Lab Marker: H. pylori Stool in Twisted colon (volvulus) (K56.2: Antigen or Urea) | Negative (K56.2) | Clinical Reference Target Range |
FDA-Monographed Medications & Public Cash Price Reference for Twisted colon (volvulus)
| Medication | Pharmacologic Class | Patient Worth-It | CMS NADAC / Unit | Typical Lowest Cash |
|---|---|---|---|---|
| Sodium Sulfate, Potassium Sulfate, Magnesium Sulfate Suprep Bowel Prep, Sodium Sulfate, Potassium Sulfate and Magnesium Sulfate • RxCUI 1001690 | Calculi Dissolution Agent | 93% | $0.3241 | $ 21.63 /mo |
| Polyethylene Glycol 3350 and Electrolytes - Unflavored Polyethylene Glycol 3350 and Electrolytes - Unflavored Generic • RxCUI 966920 | Osmotic Laxative | 92% | $0.0044 | $ 8.68 /mo |
| Moxidectin Moxidectin Generic • RxCUI 2049015 | FDA Prescription Therapeutic Agent | 83% | $1.3900 | $ 64.79 /mo |
Peer-Reviewed Human Clinical Trials & Meta-Analyses (Twisted colon (volvulus))
| Study & Plain-English Finding | Sample (N) | Rigor | Primary Source |
|---|---|---|---|
| Can This Approach Help? Inside the Latest Research on Optimising carotegrast methyl use in ulcerative colitis: patient profiling, Carotegrast methyl appears most effective in patients with moderately active ulcerative colitis with low disease activity, with week 2 and beyond as an appropriate time point for assessing efficacy. Journal of gastroenterology • 2025-12-15 • Phase III Randomized Trial | Multi-cohort | 88/100 | PMID 40982097 ↗ |
| Can This Approach Help? Inside the Latest Research on Mirikizumab impact on disease clearance in patients with moderately to severely Mirikizumab consistently demonstrated disease clearance across induction, maintenance, and long-term studies. Journal of Crohn's & colitis • 2025-09-28 • Phase III Randomized Trial | Multi-cohort | 82/100 | PMID 40651005 ↗ |
Twisted colon (volvulus) Patient Community & “People Like Me” Threads
Filter Twisted colon (volvulus) community threads and patient logs by age, biological sex, dosage, and treatment duration.